Exelixis Reveals Preliminary Financial Outcomes for 2024 and Sets Ambitious Goals for 2025
January 13, 2025 - 02:56
ALAMEDA, Calif., January 12, 2025—Exelixis, Inc. has announced its preliminary unaudited financial results for the fiscal year 2024, alongside financial guidance for the upcoming fiscal year 2025. The company is optimistic about the potential for significant advancements in clinical and regulatory efforts, particularly concerning its cabozantinib franchise.
In 2025, Exelixis plans to focus on executing its clinical programs and anticipates multiple data readouts for zanzalintinib, as well as developments across its diverse pipeline of small molecules and biotherapeutics. The company aims to leverage its existing assets while exploring new opportunities to enhance its market position.
With a clear strategy in place, Exelixis is poised for a year of growth, innovation, and impactful milestones that could shape the future of its therapeutic offerings. The commitment to advancing patient care remains at the forefront of Exelixis's mission as it navigates the challenges and opportunities ahead.
MORE NEWS
October 9, 2026 - 09:12
Finance Hiring Still Favors Degree Holders for Top Paying RolesRecruiters filling the highest paying jobs in finance continue to treat a university degree as a basic requirement, even as some employers experiment with skills based hiring. The preference is...
October 8, 2026 - 18:33
Enova Announces Date of Third Quarter 2026 Financial Results Conference CallEnova International has scheduled the release of its third quarter 2026 financial results for Thursday, October 22, 2026. The company will publish the report after the stock market closes that day,...
October 8, 2026 - 08:18
Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News EventCelcuity Inc. saw its shares drop 17.3 percent after the company announced two significant developments regarding its breast cancer treatment. The company confirmed that REVTORPYK, also known as...
October 7, 2026 - 23:47
North Dakota's State Bank Moves Forward With Stablecoin TrialThe Bank of North Dakota has launched a pilot program to test its own stablecoin, a digital currency tied to the US dollar. The project, called Roughrider Coin, aims to determine whether blockchain...